Cellero Immune Cells Provide Answers in Leukemia Study

Independent researchers cite using Cellero primary human immune cells in their recently published study on the mechanisms underlying development of acute myeloid leukemia. [1] This publication represents a broad collaborative effort across a number of renowned research institutes, including Memorial Sloan Kettering and Fred Hutchinson Cancer Research Centers, and Cornell University. The research team want…

COVID-19 blood research

COVID-19 Research at Key Bio: Convalesced Patients – Plasma & Immune Cells

Recovered patients carrying SARS-CoV-2 antibodies are being collected under Key Biologics newest IRB-Approved protocol to help drive therapeutic agent & vaccine development. Responding to the FDA’s call-to-action for convalesced plasma & other blood products collection, and to meet mounting requests from institutional & biopharmaceutical researchers in need of premium cells, Key Bio’s COVID-19 protocol is active in…